Adipose Derived Stem Cell Therapy Market Overview 2018-2026: BioRestorative Therapies, Inc., Celltex Therapeutics Corporation, Antria, Inc., Cytori Therapeutics Inc., Intrexon Corporation, Mesoblast Ltd

High effectiveness of adipose derived stem cell therapy in various medical and biotechnology research fields coupled with growing research and development activities by various research organizations is expected to boost the adoption of adipose-derived stem cell therapy in the market during the forecast period. Adipose derived stem cells (ADSCs) have various applications in medical and biomedical science field such as treatment of diabetes; regeneration of tissues partially in osteogenic, adipogenic, chondrogenic, and cardiovascular areas of medicine; bone regeneration; fat reconstruction; and myocardial and cardiovascular regeneration; among others.

Download PDF Brochure @ www.coherentmarketinsights.com/insight/request-pdf/2357

For instance, in November 2018, a peer-reviewed case study conducted using a stem cell processed by Celltex Therapeutics Corporation, showed the improvement in disease findings following systemic administration of autologous adipose derived mesenchymal stem cells (MSCs).

High cost associated with stem cell processing, need of skilled professional for managing, preserving, and scale-up of stem cell lines are the limiting factors, which are expected to restrain the growth of the adipose derived stem cell therapy market during the forecast period.

For instance, Bioinformant— a research firm engaged in stem cell research— released a data on November 2018, on cost of stem cell therapy and various key factors impacting the cost of stem cell therapy including types of stem cells used within procedure, number of treatment, and the site of the clinic. The study findings reveal the cost of stem cell therapy ranges between US$ 5,000-8,000 per patient, in some cases it may rise as much as US$ 25,000 or more depending on the complexity of the procedure.

Get Exclusive Sample Copy @ www.coherentmarketinsights.com/insight/request-sample/2357

Key players operating in the global adipose derived stem cell therapy market include BioRestorative Therapies, Inc., Celltex Therapeutics Corporation, Antria, Inc., Cytori Therapeutics Inc., Intrexon Corporation, Mesoblast Ltd., iXCells Biotechnologies, Pluristem Therapeutics, Inc., Thermo Fisher Scientific, Inc., Tissue Genesis, Inc., Cyagen US Inc., Celprogen, Inc., and Lonza Group, among others.

Adipose Derived Stem Cell Therapy Market Taxonomy:

The global adipose derived stem cell therapy market is segmented on the basis of cell type, product type, application, end user, and region.

By Cell Type

Allogeneic Stem Cells
Autologous Stem Cells
By Product Type

Cell lines
Culture Media
By Application

Therapeutic Application
Research Application
By End User

Cell & Tissue Banks
Biotechnology & Pharmaceutical organizations
Research & Academic Organizations
By Region

North America
Latin America
Europe
Asia Pacific
Middle East
Africa

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.